$1.42-0.17 (-10.69%)
Quantum Cyber N.V.
Quantum Cyber N.V. in the Healthcare sector is trading at $1.42 with a market capitalization of $46M. Wall Street consensus targets $9.00 (1 analysts), implying a +533.8% move over the next 12 months. The stock is currently 71% below its 52-week high of $4.93, remaining 18.3% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2025 | Q2 2025 | Q1 2026 |
|---|---|---|---|
| Total Revenue | $0↓ | $286,717 | $0 |
| Gross Profit | — | — | — |
| Operating Income | -$2.75M↑ | -$5.35M↓ | -$2.46M |
| Net Income | -$5.00M↓ | -$3.34M↑ | -$5.08M |
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national securi...
Quantum Cyber N. V. (NASDAQ:QUCY) shares gained around 4% after the company announced that its wholly owned subsidiary, Quantum Drones Corporation, had secured approximately $2.
Company retains investigative and litigation specialist firms and begins assessing damages in response to self-interested short-seller report.
Company Outlines Manufacturing Expansion PlansQuantum Cyber N. V.
A planned SpaceX stake has added fresh momentum to Quantum Cyber, a speculative defense technology company betting on future growth.
White Diamond Research had alleged in late June that Quantum Cyber poses a high dilution risk to investors once the company’s CEO begins unloading shares. Quantum Cyber rejected the report, calling it “materially misleading.”